Get the Stockscreener App
0.00
100.00%
-0.0001
Thermogenesis Holdings Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
See More
Previous Close:
$0.0001
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$N/A
Revenue:
$9.61M
Net Income/Loss:
$-15.74M
P/E Ratio:
0.00
EPS:
-5.14
Net Cash Flow:
$-4.59M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-61.29%
1Y Performance:
-81.10%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$0.0001
Thermogenesis Holdings Inc Stock (THMO) Company Profile
Name
Thermogenesis Holdings Inc
Sector
Industry
Phone
-
Address
-
Compare THMO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
THMO
Thermogenesis Holdings Inc
|
0.00 | 0 | 9.61M | -15.74M | -4.59M | -5.14 |
|
ABT
Abbott Laboratories
|
126.69 | 220.59B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
94.48 | 137.79B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
352.56 | 134.49B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
98.30 | 125.28B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.85 | 49.51B | 5.88B | 1.34B | 799.60M | 2.3489 |
Thermogenesis Holdings Inc Stock (THMO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-23-18 | Initiated | H.C. Wainwright | Buy |
| Dec-22-15 | Downgrade | Maxim Group | Buy → Hold |
| Nov-17-15 | Reiterated | Maxim Group | Buy |
| Sep-21-15 | Upgrade | H.C. Wainwright | Neutral → Buy |
| May-15-15 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jun-26-14 | Initiated | H.C. Wainwright | Buy |
| Apr-24-14 | Initiated | Maxim Group | Buy |
View All
Thermogenesis Holdings Inc Stock (THMO) Latest News
Cesca Therapeutics : ThermoGenesis Holdings to Announce Financial Results for the First Quarter Ended March 31, 2020 and Provide a Corporate Strategic Update - marketscreener.com
Bio Preservation Market Analysis Report 2025: Growth in - GlobeNewswire
$Induced Pluripotent Stem Cell (iPSC) Global Market - GlobeNewswire
MSN Money - MSN
Platelet Rich Plasma Market to Accelerate at 10.1% CAGR Through 2035 Driven by Regenerative Medicine Advances Across USA, Europe, APAC, and Saudi Arabia - industrytoday.co.uk
Fat Burner Supplements for Men: Effective Thermogenic Male Fat Burning Pills from Wolfson Brands - Yahoo Finance
Gloo, with former Intel CEO Gelsinger as tech head, seeks nearly $900 million valuation in IPO - MarketScreener
Navan Shares Fall in Nasdaq Debut - MarketScreener
Travel tech firm Navan falls 12% in Nasdaq debut - MarketScreener
Navan indicated to open 7% above offer price in Nasdaq debut - MarketScreener
Earnings Flash (RES) RPC, Inc. Reports Q3 Revenue $447.1M, vs. FactSet Est of $406.7M - MarketScreener
Navan slips in Nasdaq debut as US government shutdown tests IPO market - MarketScreener
Medline reveals filing for blockbuster US IPO as market recovery gains momentum - MarketScreener
Wall Street indexes climb amid earnings optimism; Nvidia gains - MarketScreener
Wall Street scales new highs on US-China trade optimism - MarketScreener
Drug developer MapLight Therapeutics valued at $704.3 million after US IPO - MarketScreener
Blank check company Space Asset Acquisition Corp files for IPO of $200 millionSEC filing - MarketScreener
Obook Shares Rise, Company Secures New Money Transmitter Licenses - MarketScreener
CGL Logistics Holdings Ltdannounces US IPO of 3,750,000 ordinary sharesSEC filing - MarketScreener
Wall Street subdued as Tesla, IBM results disappoint - MarketScreener
Clean Energy Technologies, Inc. regains compliance with Nasdaq listing requirements - MarketScreener
Almonty Up 5% In US Premarket After Filing Preliminary Base Shelf Prospectus Available for 25-Month Period - MarketScreener
Miluna Acquisition Prices $60 Million Initial Public Offering - MarketScreener
New Zealand Shares Rise Despite Wall Street Sell-Off; Genesis Energy Posts Higher Fiscal Q1 Retail Electricity Sales - MarketScreener
Redhill Biopharma receives Nasdaq staff determination notification - MarketScreener
Blank check company Armada Acquisition Corp. III files for IPO of up to $225 millionSEC filing - MarketScreener
Wall Street ends lower on mixed earnings, revived US-China trade tensions - MarketScreener
Idea Acquisition Corp files for ipo of up to $350 mln - MarketScreener
Top Midday Decliners - MarketScreener
Agencia Comercial Spirits Shares Volatile in Nasdaq Debut - MarketScreener
Texxon Shares Flat in Nasdaq Debut - MarketScreener
Wall Street stumbles on Netflix results, braces for Tesla - MarketScreener
Wall Street opens muted on Netflix earnings miss - MarketScreener
Incannex granted 180-day extension by Nasdaq to regain compliance with minimum bid price requirement - marketscreener.com
Wall Street ends mixed as earnings lift the Dow - MarketScreener
Charming Medical announces pricing of IPO & listing on Nasdaq - MarketScreener
Nasdaq Keeps Quarterly Dividend at $0.27 a Share, Payable Dec. 19 to Holders of Record as of Dec. 5 - MarketScreener
Nasdaq CEO sees robust IPO market amid shutdown; profit tops on higher trading - MarketScreener
Nasdaq Q3 revenue up 15%, beats estimates - MarketScreener
Flux Power Regains Compliance With Nasdaq Listing Rule - MarketScreener
Qt Imaging Holdings IncSubmits application to relist on Nasdaq - MarketScreener
Youxin Technology Regains Compliance With Nasdaq Listing Rules - MarketScreener
Solid volumes set to underpin US exchange results, bubble chatter in focus - MarketScreener
Nuvini regains full compliance with Nasdaq - MarketScreener
Adaptimmune Therapeutics to Voluntarily Delist From Nasdaq - MarketScreener
Youxin Technology Ltd regains compliance with Nasdaq listing requirements - MarketScreener
China-US Trade Outlook, Earnings Push Wall Street Higher Pre-Bell; Asia, Europe Up - MarketScreener
Qlosr Group to pursue new business deal off market, flags potential delisting - MarketScreener
Weshop Holdings Ltd applies to list Class A ordinary shares on Nasdaq under symbol WSHPSEC filing - MarketScreener
Wall Street ends higher as investors digest Trump trade comments - MarketScreener
Gloo Holdings Inc files for IPO of class A common stock - MarketScreener
Thermogenesis Holdings Inc Stock (THMO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.19%
0.51%
Cap:
|
Volume (24h):